Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1339-1350. doi: 10.1007/s00259-020-05057-6. Epub 2020 Oct 23.
Eur J Nucl Med Mol Imaging. 2021.
PMID: 33094433
Free PMC article.
The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research.
Ruigrok EAM, van Weerden WM, Nonnekens J, de Jong M.
Ruigrok EAM, et al.
Pharmaceutics. 2019 Oct 29;11(11):560. doi: 10.3390/pharmaceutics11110560.
Pharmaceutics. 2019.
PMID: 31671763
Free PMC article.
Review.
Item in Clipboard
Apalutamide Sensitizes Prostate Cancer to Ionizing Radiation via Inhibition of Non-Homologous End-Joining DNA Repair.
Zhang W, Liao CY, Chtatou H, Incrocci L, van Gent DC, van Weerden WM, Nonnekens J.
Zhang W, et al.
Cancers (Basel). 2019 Oct 18;11(10):1593. doi: 10.3390/cancers11101593.
Cancers (Basel). 2019.
PMID: 31635359
Free PMC article.
Item in Clipboard
Cite
Cite